Risk, returns & timeframes illustration
1 min read
February 20, 2023
by
Regan Pearson

Musk v Munger! 🥊

The ring’s heating up between billionaire battlers Musk v Munger. In the red corner, at 51 years young, weighing in at US$198.2 billion, we have Elon Musk. In the blue corner, aged 99 and the undisputed oldest investor in the world, weighing in at US$2.3 billion, we have Charlie Munger. Who will win?
1 min read
February 20, 2023
by
Regan Pearson

Musk v Munger! 🥊

The ring’s heating up between billionaire battlers Musk v Munger. In the red corner, at 51 years young, weighing in at US$198.2 billion, we have Elon Musk. In the blue corner, aged 99 and the undisputed oldest investor in the world, weighing in at US$2.3 billion, we have Charlie Munger. Who will win?
1 min read
February 20, 2023
by
Regan Pearson

Musk v Munger! 🥊

The ring’s heating up between billionaire battlers Musk v Munger. In the red corner, at 51 years young, weighing in at US$198.2 billion, we have Elon Musk. In the blue corner, aged 99 and the undisputed oldest investor in the world, weighing in at US$2.3 billion, we have Charlie Munger. Who will win?
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

Billionaire battles don’t come much bigger than Elon Musk vs Charlie Munger. ⚡

Musk is the technoking edge-lord who love loves crypto, memes and sexist jokes. Munger, on the other hand, is the Berkshire Hathaway (BERK.A, BRK.B) vice chair and value investing old-timer who hates pretty much all those things. He especially hates crypto, which last week he called ‘crypto crappo’ while speaking at the annual shareholder meeting of Daily Journal Corp (DJCO). 💩

Munger might be about as old as a 150kg prehistoric Aotearoa penguin, but he has no problem squaring up against Musk when it comes to which electric vehicle (EV) maker he’d back for Berkshire’s portfolio. 🐧 While Tesla (TSLA) dominated sales of EVs in the US in 2022, making up 65% of all EVs sold, Munger says when it comes to China’s BYD (Build Your Dreams), he reckons they’re so far ahead of Tesla ‘it’s almost ridiculous’. 

In fact, BYD is leaving most other EV makers in their dust. 🚗💨 The company sold 1.86 million EVs in China last year, compared to the 400,000 sold by very-much-second-place Tesla. Munger also noted that while BYD was able to increase prices in China last year, Tesla reduced prices, twice. Wah wah. 🎺 

Munger’s comments were enough to fire up investing heavy-weight Cathie Wood. Wood came out swinging, saying Munger just doesn’t get it when it comes to Tesla, which she thinks could be worth a whopping US$1,500 per share. 

There’s been no such love for electric truck maker Rivian (RIVN), however. After listing to boisterous fanfare in 2021, the company’s share price has fizzled as they burn through the cash. 💸 Big investor Ford (F) has also been steadily selling down their 12% stake in Rivian as they focus on getting their own truck, the F150 Lightning, into the market. ⚡ Billionaire fisty-cuffs at dawn?

Regan Pearson
Finance writer
Linkedin

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more
8 min read
Jan 21, 2025

2 Things Wall Street’s watching in 2025

2024 was a big year for AI, with Nvidia stocks soaring. Now what? Is it time for the return of IPOs? Some Wall Streeters have their eyes locked on potential 2025 high profile IPOs. And you’ve heard of ‘bits’, now could be the time to discover ‘qubits’ and how they could impact share markets in the long term.
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more
8 min read
Jan 21, 2025

2 Things Wall Street’s watching in 2025

2024 was a big year for AI, with Nvidia stocks soaring. Now what? Is it time for the return of IPOs? Some Wall Streeters have their eyes locked on potential 2025 high profile IPOs. And you’ve heard of ‘bits’, now could be the time to discover ‘qubits’ and how they could impact share markets in the long term.
Read more